EA201690368A1 - Таблетка дулоксетина с энтеросолюбильным покрытием - Google Patents

Таблетка дулоксетина с энтеросолюбильным покрытием

Info

Publication number
EA201690368A1
EA201690368A1 EA201690368A EA201690368A EA201690368A1 EA 201690368 A1 EA201690368 A1 EA 201690368A1 EA 201690368 A EA201690368 A EA 201690368A EA 201690368 A EA201690368 A EA 201690368A EA 201690368 A1 EA201690368 A1 EA 201690368A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tablet
core
entrolooting
duloksetin
coating
Prior art date
Application number
EA201690368A
Other languages
English (en)
Other versions
EA029916B1 (ru
Inventor
Йоланта Трела
Эвелина Ковальска
Original Assignee
Адамед Сп. З О.О.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52483131&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201690368(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Адамед Сп. З О.О. filed Critical Адамед Сп. З О.О.
Publication of EA201690368A1 publication Critical patent/EA201690368A1/ru
Publication of EA029916B1 publication Critical patent/EA029916B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Предложена таблетка дулоксетина с энтеросолюбильным покрытием, состоящая из ядра, содержащего дулоксетина гидрохлорид, который однородно смешан без применения какой-либо жидкости с прессуемым сахаром, причем количество указанного прессуемого сахара составляет 60-85% по массе из расчета на общую массу ядра, и, необязательно, с одним или более фармацевтически приемлемыми вспомогательными веществами, и энтеросолюбильного покрытия, нанесенного непосредственно на указанное ядро и содержащего сополимер метакриловой кислоты и этилакрилата (1:1) в качестве единственного полимера, устойчивого к действию желудочного сока, и одно или более фармацевтически приемлемых вспомогательных веществ, а также способ получения указанной таблетки.
EA201690368A 2013-08-21 2014-08-18 Таблетка дулоксетина с энтеросолюбильным покрытием EA029916B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL405111A PL224543B1 (pl) 2013-08-21 2013-08-21 Dojelitowa tabletka duloksetyny
PCT/IB2014/063955 WO2015025261A1 (en) 2013-08-21 2014-08-18 Duloxetine enteric coated tablet

Publications (2)

Publication Number Publication Date
EA201690368A1 true EA201690368A1 (ru) 2016-06-30
EA029916B1 EA029916B1 (ru) 2018-05-31

Family

ID=52483131

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690368A EA029916B1 (ru) 2013-08-21 2014-08-18 Таблетка дулоксетина с энтеросолюбильным покрытием

Country Status (12)

Country Link
EP (1) EP3035919B1 (ru)
AU (1) AU2014310317B2 (ru)
EA (1) EA029916B1 (ru)
HK (1) HK1224197A1 (ru)
MX (1) MX2016002269A (ru)
MY (1) MY190111A (ru)
PH (1) PH12016500245A1 (ru)
PL (1) PL224543B1 (ru)
SG (1) SG11201600886YA (ru)
UA (1) UA119852C2 (ru)
WO (1) WO2015025261A1 (ru)
ZA (1) ZA201601724B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018172361A (ja) * 2016-10-14 2018-11-08 大原薬品工業株式会社 光安定性を改善した、デュロキセチンを含有する固形製剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007433A (ko) 1986-12-22 1988-08-27 메리 앤 터커 3-아릴옥시-3-치환된 프로판아민
US5508276A (en) 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
EP1424079A1 (en) 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
BRPI0711606A2 (pt) 2006-05-22 2012-02-14 Teva Pharma formulações de hidrocloreto de duloxetina de liberação retardada
WO2008020286A2 (en) 2006-08-14 2008-02-21 Torrent Pharmaceuticals Limited Pharmaceutical compositions of duloxetine
EP1938840A1 (en) 2006-12-27 2008-07-02 LEK Pharmaceuticals D.D. Duloxetine composition
GB0712220D0 (en) 2007-06-23 2007-08-01 Arrow Int Ltd Duloxetine formulation
WO2009066181A2 (en) 2007-07-09 2009-05-28 Combino Pharm, S.L. Oral delayed-release duloxentine hydrochloride pellets
EP2182929A2 (en) 2007-07-13 2010-05-12 Synthon B.V. Duloxetine formulations
WO2009087657A2 (en) 2007-11-03 2009-07-16 Alkem Laboratories Ltd. Stable pharmaceutical composition of duloxetine and process for its preparation
US20110150942A1 (en) 2008-06-13 2011-06-23 Natalija Zajc Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
EP2133072A1 (en) 2008-06-13 2009-12-16 KRKA, D.D., Novo Mesto Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives
ES2376095B1 (es) 2008-10-02 2013-01-24 Laboratorios Del Dr. Esteve, S.A. Pellets entéricos de duloxetina.
CN101756960B (zh) * 2008-12-26 2012-06-27 上海中西制药有限公司 一种度洛西汀肠溶制剂及其芯材和制备方法

Also Published As

Publication number Publication date
MX2016002269A (es) 2016-06-06
EP3035919A1 (en) 2016-06-29
HK1224197A1 (zh) 2017-08-18
ZA201601724B (en) 2017-09-27
PH12016500245A1 (en) 2016-05-16
MY190111A (en) 2022-03-29
EA029916B1 (ru) 2018-05-31
WO2015025261A1 (en) 2015-02-26
AU2014310317A1 (en) 2016-03-03
AU2014310317B2 (en) 2019-03-07
PL224543B1 (pl) 2017-01-31
PL405111A1 (pl) 2015-03-02
UA119852C2 (uk) 2019-08-27
EP3035919B1 (en) 2019-10-09
SG11201600886YA (en) 2016-03-30

Similar Documents

Publication Publication Date Title
BR112018010018A2 (pt) moduladores de ror-gama
BR112018006920A2 (pt) agonistas dos receptores de glucagon
EA201790785A1 (ru) Производные тетрагидроизохинолина
BR112018008564A2 (pt) ?dispositivo e método de comunicação?
EP4219718A3 (en) Compositions and methods for modulating complement factor b expression
BR112018013011A2 (pt) composições de alimento para animais de estimação
EA201890002A1 (ru) Положительные аллостерические модуляторы мускаринового рецептора м2
EA201990223A1 (ru) Фармацевтическая композиция для перорального приема с контролируемой скоростью растворения, содержащая пеллеты с замедленным высвобождением, содержащие тамсулозина гидрохлорид
IL247137A0 (en) A cross-linked hydrophobic acrylic polymer containing 2-phenoxy-tetraethylene-glycol acrylate, for use in the preparation of an intraocular lens
BR112015019616A2 (pt) formulação de filtro solar
PH12016501965A1 (en) S1p modulator immediate release dosage regimen
EA201790912A1 (ru) Гетероциклическое соединение
WO2014194226A3 (en) Methods of treatment and compositions with xanthine oxidase inhibitors
BR112017000211A2 (pt) composição de revestimento estável
EP3768253A4 (en) Deuterated analogs of d-& x3b2;-hydroxybutyric acid and uses thereof
IN2014DN06965A (ru)
EA201991373A1 (ru) МОДУЛЯТОРЫ ROR ГАММА (RORγ)
EA201690368A1 (ru) Таблетка дулоксетина с энтеросолюбильным покрытием
AR099066A1 (es) Polímeros que comprenden grupos de ácido sulfónico
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
FR3045392B1 (fr) Dispositif pour le traitement d'un sujet par combinaison notamment de la lithotherapie, la chromotherapie, la luminotherapie et la musicotherapie
EA201490705A1 (ru) Загущающие виниловые сополимеры
BR112018070547A2 (pt) agonistas de rara para o tratamento de aml e mds
EA201690219A1 (ru) Агонисты рецептора вазопрессина-2
FR3027395B1 (fr) Composition pour dosage immuno-enzymatique par immunofluorescence et ses utilisations

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU